Literature DB >> 18035234

Pharmacotherapy for insomnia.

Syed H Tariq1, Shailaja Pulisetty.   

Abstract

Hypnotics are commonly use in the treatment of insomnia, and hypnotic use among older adults is more prevalent than with younger adults. Unfortunately, the use of hypnotics is not well studied in the ever-growing geriatric population and the magnitude of the medication benefit is usually not impressive. Insomnia in older adults is usually treated with benzodiazepines, nonbenzodiazepines, and other agents, such as trazodone, valerian, and melatonin. Using appropriately selected agents and therapy initiated with a low dose and careful monitoring of the patient could minimize common unwanted side effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18035234     DOI: 10.1016/j.cger.2007.08.009

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  16 in total

Review 1.  The globalization of traditional medicine in northern peru: from shamanism to molecules.

Authors:  Rainer W Bussmann
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-28       Impact factor: 2.629

Review 2.  Low-dose doxepin: in the treatment of insomnia.

Authors:  Juliane Weber; M Asif A Siddiqui; Antona J Wagstaff; Paul L McCormack
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

3.  Aromatherapy with single essential oils can significantly improve the sleep quality of cancer patients: a meta-analysis.

Authors:  Hui Cheng; Lu Lin; Shaotong Wang; Yueyue Zhang; Tingting Liu; Yang Yuan; Qiuyun Chen; Li Tian
Journal:  BMC Complement Med Ther       Date:  2022-07-14

4.  Diagnosis and treatment of chronic insomnia.

Authors:  Sahoo Saddichha
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

5.  Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury.

Authors:  Sarah E Tom; Emerson M Wickwire; Yujin Park; Jennifer S Albrecht
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

6.  Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.

Authors:  Mai Yamamoto; Ken Inada; Minori Enomoto; Mitsunari Habukawa; Takahisa Hirose; Yuichi Inoue; Jun Ishigooka; Yuichi Kamei; Tsuyoshi Kitajima; Masayuki Miyamoto; Hideto Shinno; Katsuji Nishimura; Motohiro Ozone; Masahiro Takeshima; Mayumi Suzuki; Hidehisa Yamashita; Kazuo Mishima
Journal:  Neuropsychopharmacol Rep       Date:  2020-12-01

7.  Increased risk of hospitalization related to motor vehicle accidents among people taking zolpidem: a case-crossover study.

Authors:  Yao-Hsu Yang; Jung-Nien Lai; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  J Epidemiol       Date:  2010-10-23       Impact factor: 3.211

Review 8.  Impact of physical exercise in cancer survivors during and after antineoplastic treatments.

Authors:  Martina Ferioli; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Simona Ultimo; Silvano Capitani; Luca M Neri
Journal:  Oncotarget       Date:  2018-02-08

Review 9.  Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.

Authors:  Bernardo Dell'Osso; Umberto Albert; Anna Rita Atti; Claudia Carmassi; Giuseppe Carrà; Fiammetta Cosci; Valeria Del Vecchio; Marco Di Nicola; Silvia Ferrari; Arianna Goracci; Felice Iasevoli; Mario Luciano; Giovanni Martinotti; Maria Giulia Nanni; Alessandra Nivoli; Federica Pinna; Nicola Poloni; Maurizio Pompili; Gaia Sampogna; Ilaria Tarricone; Sarah Tosato; Umberto Volpe; Andrea Fiorillo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-30       Impact factor: 2.570

Review 10.  Valerian: no evidence for clinically relevant interactions.

Authors:  Olaf Kelber; Karen Nieber; Karin Kraft
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.